Per Section 9008 of the Patient
Protection and Affordable Care Act (ACA), Public Law 111-148 (124
Stat. 119 (2010))form 8947 is used to report controlled group
status and information on orphan drug credits allowed for covered
pharmaceutical manufacturers and importers.
Requested by LB&I the
special team assembled to implement section 908 of ACA: To allow
that subsequent year filers would not have to repeat sending in the
entire drug data listed on their initial year filing of Form 8947
(for some filers, hundreds of pages), the form is expanded from 6
pages to 9 pages. Part I is renamed Schedule A. Schedules B, C, and
D are added. The Continuation Sheet for Part II is deleted. The
instructions are revised to conform to Temporary Regulations
sections 51.1T through 51.12T, and section 51.6302-1T. These
regulations obsolete Notices 2011-9 and 2011-46, and Rev. Proc.
2011-24. These program changes result in a decrease in estimated
burden time of 96 hours due to agency discretion.
$0
No
No
Yes
Yes
No
Uncollected
Michael Cyrus 202
927-9545
No
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.